See if short-term supervised resistance training improves muscle health and function in frail older adults with type 2 diabetes
Official title: Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
Run by Fundación para la Investigación del Hospital Clínico de Valencia · NCT07828847 · Data updated 2026-11-12
This study tests whether a brief, supervised resistance training program can improve skeletal muscle health and physical function in frail adults over 65 who have type 2 diabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 83 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Fundación para la Investigación del Hospital Clínico de Valencia Academic / other |
| Locations | 1 site (Valencia) |
| Status | Recruiting |
| Started | January 29, 2022 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT07828847 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 65 with frailty and type 2 diabetes managed with metformin, not currently in a resistance training program.
✕Probably not a fit
Individuals without frailty, without type 2 diabetes, or those already engaging in resistance training may see limited or no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial investigates the link between skeletal muscle mitochondrial dysfunction and frailty in older adults and whether a short, supervised resistance training intervention can improve muscle bioenergetics and physical performance. It includes older adults with frailty and type 2 diabetes, as well as control groups of healthy young and older adults. Participants will undergo a brief resistance training program and assessments of muscle function and metabolic biomarkers. The study aims to clarify cellular mechanisms related to frailty and the potential benefits of exercise for this population. Outcomes focus on feasibility, safety, and changes in muscle health and functional measures.
Why it matters
Potential benefit: If successful, the intervention could improve muscle strength, endurance, and overall function in frail older adults with type 2 diabetes.
How similar studies have gone: Prior research shows resistance training can improve muscle function in older adults, though the specific link to mitochondrial dysfunction in frailty with diabetes is an area of ongoing study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion criteria for young controls * Healthy young adults (18-35 years old) * Without any pathology or treatment * Inclusion criteria for older controls * Healthy older adults (65 years or older) * Not currently enrolled in a resistance training program * Inclusion criteria for cases * Age over 65 years * Diagnosis of frailty or robustness * Diagnosis of type 2 diabetes mellitus * Glycosylated hemoglobin (HbA1c) less than 9% * Treatment with metformin * Not currently enrolled in a resistance training program Exclusion Criteria: * Exclusion criteria for young controls * Pregnancy or suspected pregnancy * Body mass index greater than 35 kg/m2 * Treatment within the last 30 days with oral corticosteroids * Edema or severe fluid regulation disorders that could alter bioimpedance results * Allergy to the local anesthetic mepivacaine * Prostheses, metal implants, or surgical staples lodinated or barium contrast for other imaging tests within the last 7 days * Exclusion criteria for older controls * Decompensated and uncontrolled chronic diagnoses * Body mass index greater than 35 kg/m2 * Treatment within the last 30 days with oral corticosteroids * Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease (COPD). * Severe edema or fluid regulation disorders that could alter bioimpedance results * Allergy to the local anesthetic mepivacaine * Prostheses, metal implants, or surgical staples Iodinated or barium contrast for other imaging tests in the last 7 days * Exclusion criteria for cases * Diagnosis of pre-frailty * Age over 80 years * Body mass index greater than 35 kg/m2 * Time since onset of diabetes mellitus type 2 less than 10 years * Treatment with insulin * Treatment with allopurinol * Treatment with anticoagulant or antiplatelet drugs * Treatment within the last 30 days with oral corticosteroids * Advanced chronic complications of diabetes mellitus type 2 : Renal failure (clearance \<30 ml/min/m2) Macroalbuminuria greater than 200 mg/g Ischemic vascular diseases (acute myocardial infarction) Myocardial infarction, angina, stroke) Proliferative retinopathy or laser therapy Ulcerated diabetic foot or lower limb amputations, except for digital amputations * Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease * Physical limitations in the lower limbs (acute or acute-on-chronic inflammatory processes, limited joint range of motion, chronic pain (visual analogue scale for pain \> or = 4, etc.) * Senile dementia * Edema or severe fluid regulation disorders that may alter bioimpedance results * Allergy to the local anesthetic mepivacaine * Pacemaker, metallic prostheses or implants, surgical staples, and radiopaque tubes or catheters Iodinated or barium contrast for other imaging tests within the last 7 days
Where it's running
-
University of Valencia/Hospital Clínico Universitario de València,
Valencia, Spain Recruiting
Study contacts
- Study coordinator: Maria Carmen Gómez Cabrera, Doctor in Physiology
- Email: carmen.gomez@uv.es
- Phone: +34-666871805
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
Empagliflozin, Metformin, or both for muscle energy in adults with type 2 diabetes
This study tests whether empagliflozin, metformin, or their combination can improve skeletal muscle oxidative capacity and microvascular reactivity in adults recently diagnosed with type 2 diabetes.
-
Perioperative Meditation Music for Type 2 Diabetes Patients Undergoing Elective Surgery
We’re testing whether playing self-selected meditation music around surgery helps adults with type 2 diabetes stay calm, sleep better, and keep blood sugar steadier.
-
How metformin works in people with or without the SLC16A11 risk variant
This study tests whether the SLC16A11 genetic variant changes how adults with type 2 diabetes respond to metformin over 6 months.
-
Broccoli sprout extract and high-intensity exercise do they change immunometabolism in healthy adults?
This study tests whether taking broccoli sprout extract, doing short bursts of high-intensity exercise, or both, for four days affects markers of immunometabolism and inflammation in healthy young adults.
-
Impact of a Multicomponent Exercise Program on Function in Frail Adults in Intermediate Care
A randomized trial tests whether a personalized multicomponent exercise program can improve function and reduce frailty in adults admitted to an intermediate care hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.